囊性纤维化患者-话题@MedSci

#囊性纤维化患者#

26篇内容 | 732人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2006178, encodeId=a27f20061e8b8, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, objectTitle=Infection: 囊性纤维化患者患有严重COVID-19临床病程和危险因素分析, objectType=article, longId=264978, objectId=1d2c2649e808, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d2c2649e808, replyNumber=0, likeNumber=51, createdTime=2022-04-30, rootId=0, userName=ms5906905816781247, userId=9d712500079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d2c2649e808, moduleTitle=Infection: 囊性纤维化患者患有严重COVID-19临床病程和危险因素分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d2c2649e808)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006177, encodeId=d5bc20061e7b0, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, objectTitle=JCEM：青少年和青壮年囊性纤维化患者持续血糖监测与OGTT的充分关系。, objectType=article, longId=218808, objectId=566f218808f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=566f218808f9, replyNumber=0, likeNumber=49, createdTime=2021-12-29, rootId=0, userName=ms5906905816781247, userId=9d712500079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=566f218808f9, moduleTitle=JCEM：青少年和青壮年囊性纤维化患者持续血糖监测与OGTT的充分关系。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=566f218808f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006179, encodeId=3ac320061e95e, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, objectTitle=Dig Liver Dis：囊性纤维化患者中血清胆汁酸和甘醇脱氧胆酸水平可以作为肝脏病变的生物标志物, objectType=article, longId=292820, objectId=558129282003, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=558129282003, replyNumber=0, likeNumber=32, createdTime=2022-08-29, rootId=0, userName=ms5906905816781247, userId=9d712500079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=558129282003, moduleTitle=Dig Liver Dis：囊性纤维化患者中血清胆汁酸和甘醇脱氧胆酸水平可以作为肝脏病变的生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=558129282003)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006176, encodeId=cb2020061e62b, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, objectTitle=Lancet Respir Med：Tezacaftor-iVacaftor治疗携带CFTR Phe508del突变的囊性纤维化患者的长期预后, objectType=article, longId=207122, objectId=8d1120e122ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d1120e122ef, replyNumber=0, likeNumber=38, createdTime=2021-05-24, rootId=0, userName=ms5906905816781247, userId=9d712500079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d1120e122ef, moduleTitle=Lancet Respir Med：Tezacaftor-iVacaftor治疗携带CFTR Phe508del突变的囊性纤维化患者的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d1120e122ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006174, encodeId=eb6820061e487, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, objectTitle=Diabetologia：成人囊性纤维化患者口服葡萄糖对低血糖的反应, objectType=article, longId=197827, objectId=223419e827ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=223419e827ec, replyNumber=0, likeNumber=31, createdTime=2020-10-06, rootId=0, userName=ms5906905816781247, userId=9d712500079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=223419e827ec, moduleTitle=Diabetologia：成人囊性纤维化患者口服葡萄糖对低血糖的反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=223419e827ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006175, encodeId=b6e820061e5dd, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, objectTitle=Clinica Chimica Acta：土耳其囊性纤维化患者CFTR基因突变和新变异？, objectType=article, longId=199107, objectId=df8b19910ed1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df8b19910ed1, replyNumber=0, likeNumber=44, createdTime=2020-08-14, rootId=0, userName=ms5906905816781247, userId=9d712500079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df8b19910ed1, moduleTitle=Clinica Chimica Acta：土耳其囊性纤维化患者CFTR基因突变和新变异？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df8b19910ed1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006173, encodeId=88da20061e3f4, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, objectTitle=Chest：体重不足的囊性纤维化患者肺移植后的生存率可以接受, objectType=article, longId=186494, objectId=11b418649458, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11b418649458, replyNumber=0, likeNumber=40, createdTime=2020-12-02, rootId=0, userName=ms5906905816781247, userId=9d712500079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11b418649458, moduleTitle=Chest：体重不足的囊性纤维化患者肺移植后的生存率可以接受, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11b418649458)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006170, encodeId=85a220061e0aa, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, objectTitle=MS1819-SD结合PERT治疗严重外分泌胰腺功能不全的囊性纤维化患者, objectType=article, longId=175072, objectId=24d81e507264, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24d81e507264, replyNumber=0, likeNumber=32, createdTime=2020-04-28, rootId=0, userName=ms5906905816781247, userId=9d712500079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24d81e507264, moduleTitle=MS1819-SD结合PERT治疗严重外分泌胰腺功能不全的囊性纤维化患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24d81e507264)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006172, encodeId=eaf820061e286, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, objectTitle=FDA批准Trikafta用于治疗CFTR基因突变的囊性纤维化患者, objectType=article, longId=181775, objectId=510f181e75bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=510f181e75bd, replyNumber=0, likeNumber=42, createdTime=2020-07-24, rootId=0, userName=ms5906905816781247, userId=9d712500079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=510f181e75bd, moduleTitle=FDA批准Trikafta用于治疗CFTR基因突变的囊性纤维化患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=510f181e75bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006171, encodeId=a75c20061e192, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, objectTitle=Eur Respir J：炎症和感染对早期囊性纤维化患者结构性肺病的累积效应, objectType=article, longId=175322, objectId=29d21e53224e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29d21e53224e, replyNumber=0, likeNumber=42, createdTime=2019-11-06, rootId=0, userName=ms5906905816781247, userId=9d712500079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29d21e53224e, moduleTitle=Eur Respir J：炎症和感染对早期囊性纤维化患者结构性肺病的累积效应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29d21e53224e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006169, encodeId=c2bf2006169fa, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, objectTitle=BMC Gastroenterology：标准和改良肠道准备在成人囊性纤维化患者中行结肠镜检查时的疗效比较, objectType=article, longId=172248, objectId=64c01e224875, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64c01e224875, replyNumber=0, likeNumber=32, createdTime=2019-08-27, rootId=0, userName=ms5906905816781247, userId=9d712500079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64c01e224875, moduleTitle=BMC Gastroenterology：标准和改良肠道准备在成人囊性纤维化患者中行结肠镜检查时的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64c01e224875)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006168, encodeId=ae882006168da, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, objectTitle=2019 CFF共识指南：囊性纤维化患者肺移植推荐, objectType=article, longId=164448, objectId=a942164448b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a942164448b1, replyNumber=0, likeNumber=29, createdTime=2019-08-31, rootId=0, userName=ms5906905816781247, userId=9d712500079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a942164448b1, moduleTitle=2019 CFF共识指南：囊性纤维化患者肺移植推荐, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a942164448b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006167, encodeId=afde200616e47, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, objectTitle=Vertex公司的SYMDEKO获澳大利亚批准，用于治疗12岁以上CFTR基因突变的囊性纤维化患者, objectType=article, longId=162243, objectId=fc3a1622439e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc3a1622439e, replyNumber=0, likeNumber=32, createdTime=2019-06-06, rootId=0, userName=ms5906905816781247, userId=9d712500079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc3a1622439e, moduleTitle=Vertex公司的SYMDEKO获澳大利亚批准，用于治疗12岁以上CFTR基因突变的囊性纤维化患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc3a1622439e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006166, encodeId=8ad82006166f9, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, objectTitle=Gastroenterology：囊性纤维化患者结肠癌筛查模式的成本效益研究, objectType=article, longId=124940, objectId=70251249402c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70251249402c, replyNumber=0, likeNumber=41, createdTime=2018-05-04, rootId=0, userName=ms5906905816781247, userId=9d712500079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70251249402c, moduleTitle=Gastroenterology：囊性纤维化患者结肠癌筛查模式的成本效益研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70251249402c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006165, encodeId=c05f20061659a, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, objectTitle=JCEM：维生素D对于成人囊性纤维化患者肠道菌群的影响, objectType=article, longId=120854, objectId=6d2e12085499, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d2e12085499, replyNumber=0, likeNumber=35, createdTime=2018-04-11, rootId=0, userName=ms5906905816781247, userId=9d712500079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d2e12085499, moduleTitle=JCEM：维生素D对于成人囊性纤维化患者肠道菌群的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d2e12085499)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006162, encodeId=207d200616216, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, objectTitle=Thorax：口服抗菌药物治疗的囊性纤维化患者肺病加重对临床结局有何影响？, objectType=article, longId=95905, objectId=e19a9590597, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e19a9590597, replyNumber=0, likeNumber=44, createdTime=2017-09-23, rootId=0, userName=ms5906905816781247, userId=9d712500079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e19a9590597, moduleTitle=Thorax：口服抗菌药物治疗的囊性纤维化患者肺病加重对临床结局有何影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e19a9590597)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006161, encodeId=332c200616135, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, objectTitle=Chest：肺功能FEV1 <30％的成人囊性纤维化患者的生存现状分析, objectType=article, longId=88640, objectId=14c3886402d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14c3886402d, replyNumber=0, likeNumber=35, createdTime=2017-09-13, rootId=0, userName=ms5906905816781247, userId=9d712500079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14c3886402d, moduleTitle=Chest：肺功能FEV1 <30％的成人囊性纤维化患者的生存现状分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14c3886402d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006160, encodeId=e3002006160da, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, objectTitle=Science：多药耐药性感染在囊性纤维化患者中扩散, objectType=article, longId=82283, objectId=9f1d8228368, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f1d8228368, replyNumber=0, likeNumber=36, createdTime=2016-11-16, rootId=0, userName=ms5906905816781247, userId=9d712500079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f1d8228368, moduleTitle=Science：多药耐药性感染在囊性纤维化患者中扩散, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f1d8228368)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006163, encodeId=152d200616353, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, objectTitle=Chest：囊性纤维化患者的中枢神经功能障碍表现, objectType=article, longId=97509, objectId=d8a99e509a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8a99e509a6, replyNumber=0, likeNumber=32, createdTime=2017-08-08, rootId=0, userName=ms5906905816781247, userId=9d712500079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8a99e509a6, moduleTitle=Chest：囊性纤维化患者的中枢神经功能障碍表现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8a99e509a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2006164, encodeId=7fe1200616492, content=<a href='/topic/show?id=a5c54038142' target=_blank style='color:#2F92EE;'>#囊性纤维化患者#</a>, objectTitle=Lancet respir med：lumacaftor与依法卡托联合治疗对6-11岁携带F508del-CFTR纯合突变的肺囊性纤维化患者的疗效如何？, objectType=article, longId=101423, objectId=a07f101423fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a07f101423fa, replyNumber=0, likeNumber=48, createdTime=2017-10-17, rootId=0, userName=ms5906905816781247, userId=9d712500079, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a07f101423fa, moduleTitle=Lancet respir med：lumacaftor与依法卡托联合治疗对6-11岁携带F508del-CFTR纯合突变的肺囊性纤维化患者的疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a07f101423fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

囊性纤维化患者

2020-05-29

ms5906905816781247 (审核中...)

前往app查看评论内容

#囊性纤维化患者#

Infection: 囊性纤维化患者患有严重COVID-19临床病程和危险因素分析

2022-04-30

ms5906905816781247 (审核中...)

前往app查看评论内容

#囊性纤维化患者#

JCEM：青少年和青壮年囊性纤维化患者持续血糖监测与OGTT的充分关系。

2021-12-29

ms5906905816781247 (审核中...)

前往app查看评论内容

#囊性纤维化患者#

Dig Liver Dis：囊性纤维化患者中血清胆汁酸和甘醇脱氧胆酸水平可以作为肝脏病变的生物标志物

2022-08-29

ms5906905816781247 (审核中...)

前往app查看评论内容

#囊性纤维化患者#

Lancet Respir Med：Tezacaftor-iVacaftor治疗携带CFTR Phe508del突变的囊性纤维化患者的长期预后

2021-05-24

ms5906905816781247 (审核中...)

前往app查看评论内容

#囊性纤维化患者#

Diabetologia：成人囊性纤维化患者口服葡萄糖对低血糖的反应

2020-10-06

ms5906905816781247 (审核中...)

前往app查看评论内容

#囊性纤维化患者#

Clinica Chimica Acta：土耳其囊性纤维化患者CFTR基因突变和新变异？

2020-08-14

ms5906905816781247 (审核中...)

前往app查看评论内容

#囊性纤维化患者#

Chest：体重不足的囊性纤维化患者肺移植后的生存率可以接受

2020-12-02

ms5906905816781247 (审核中...)

前往app查看评论内容

#囊性纤维化患者#

MS1819-SD结合PERT治疗严重外分泌胰腺功能不全的囊性纤维化患者

2020-04-28

ms5906905816781247 (审核中...)

前往app查看评论内容

#囊性纤维化患者#

FDA批准Trikafta用于治疗CFTR基因突变的囊性纤维化患者

2020-07-24

ms5906905816781247 (审核中...)

前往app查看评论内容

#囊性纤维化患者#

Eur Respir J：炎症和感染对早期囊性纤维化患者结构性肺病的累积效应

2019-11-06

ms5906905816781247 (审核中...)

前往app查看评论内容

#囊性纤维化患者#

BMC Gastroenterology：标准和改良肠道准备在成人囊性纤维化患者中行结肠镜检查时的疗效比较

2019-08-27

ms5906905816781247 (审核中...)

前往app查看评论内容

#囊性纤维化患者#

2019 CFF共识指南：囊性纤维化患者肺移植推荐

2019-08-31

ms5906905816781247 (审核中...)

前往app查看评论内容

#囊性纤维化患者#

Vertex公司的SYMDEKO获澳大利亚批准，用于治疗12岁以上CFTR基因突变的囊性纤维化患者

2019-06-06

ms5906905816781247 (审核中...)

前往app查看评论内容

#囊性纤维化患者#

Gastroenterology：囊性纤维化患者结肠癌筛查模式的成本效益研究

2018-05-04

ms5906905816781247 (审核中...)

前往app查看评论内容

#囊性纤维化患者#

JCEM：维生素D对于成人囊性纤维化患者肠道菌群的影响

2018-04-11

ms5906905816781247 (审核中...)

前往app查看评论内容

#囊性纤维化患者#

Thorax：口服抗菌药物治疗的囊性纤维化患者肺病加重对临床结局有何影响？

2017-09-23

ms5906905816781247 (审核中...)

前往app查看评论内容

#囊性纤维化患者#

Chest：肺功能FEV1 <30％的成人囊性纤维化患者的生存现状分析

2017-09-13

ms5906905816781247 (审核中...)

前往app查看评论内容

#囊性纤维化患者#

Science：多药耐药性感染在囊性纤维化患者中扩散

2016-11-16

ms5906905816781247 (审核中...)

前往app查看评论内容

#囊性纤维化患者#

Chest：囊性纤维化患者的中枢神经功能障碍表现

2017-08-08

ms5906905816781247 (审核中...)

前往app查看评论内容

#囊性纤维化患者#

Lancet respir med：lumacaftor与依法卡托联合治疗对6-11岁携带F508del-CFTR纯合突变的肺囊性纤维化患者的疗效如何？

2017-10-17

科室
- - 订阅+
  - 更多科室
工具
服务